Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-10-18

Clinical Trial Update: The Safety of a High-Dose, Rapid Infusion of Iron Sucrose [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety of a high-dose, rapid infusion of iron sucrose for iron deficiency was withdrawn before completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iron sucrose (iron sucrose)

Snippet

Sponsor: The Guthrie Clinic | Conditions: Iron Deficiency | Phase 2 | Status: WITHDRAWN